Ablative fractional laser improves treatment of actinic keratoses with Ingenol Mebutate
暂无分享,去创建一个
[1] A. Offidani,et al. Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] A. Offidani,et al. Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series , 2016, SpringerPlus.
[3] M. Haedersdal,et al. Ablative fractional laser intensifies treatment outcome of scalp actinic keratoses with ingenol mebutate: a case report , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] E. Stockfleth,et al. Field Treatment of Actinic Keratosis With Ingenol Mebutate. , 2016, Journal of Drugs in Dermatology.
[5] S. Shumack,et al. Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] M. Sannino,et al. Flash-lamp pulsed-dye laser treatment of keloids: results of an observational study. , 2015, Photomedicine and laser surgery.
[7] F. Lacarrubba,et al. Reply to: "Laser assisted drug delivery: enhanced response to ingenol mebutate after ablative fractional laser treatment". , 2015, Journal of American Academy of Dermatology.
[8] P. Hevezi,et al. Laser-assisted drug delivery: enhanced response to ingenol mebutate after ablative fractional laser treatment. , 2015, Journal of the American Academy of Dermatology.
[9] H. Wulf,et al. Fractional laser‐mediated photodynamic therapy of high‐risk basal cell carcinomas – a randomized clinical trial , 2015, The British journal of dermatology.
[10] B. Dréno,et al. Management of actinic keratosis: a practical report and treatment algorithm from AKTeamTM expert clinicians , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.
[11] M. Sannino,et al. Deep pulse fractional CO2 laser combined with a radiofrequency system: results of a case series. , 2014, Photomedicine and laser surgery.
[12] J. Gardette,et al. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP) , 2014, European Journal of Dermatology.
[13] Alvin L. K. Chia,et al. Actinic Keratosis: Rationale and Management , 2014, Dermatology and Therapy.
[14] Sanjeev Gupta,et al. Ingenol mebutate: A novel topical drug for actinic keratosis , 2013, Indian dermatology online journal.
[15] N. Swanson,et al. Clinical findings using ingenol mebutate gel to treat actinic keratoses. , 2013, Journal of the American Academy of Dermatology.
[16] Aditya K. Gupta,et al. Interventions for actinic keratoses. , 2012, The Cochrane database of systematic reviews.
[17] E. Stockfleth. The paradigm shift in treating actinic keratosis: a comprehensive strategy. , 2012, Journal of drugs in dermatology : JDD.
[18] R. Anderson,et al. The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[19] H. Wulf,et al. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial , 2012, The British journal of dermatology.
[20] Neil Swanson,et al. Ingenol mebutate gel for actinic keratosis. , 2012, The New England journal of medicine.
[21] G. Goldenberg,et al. An update on nonmelanoma skin cancer. , 2011, The Journal of clinical and aesthetic dermatology.
[22] S. Ibrahim,et al. Actinic keratoses: a comprehensive update. , 2009, The Journal of clinical and aesthetic dermatology.
[23] H. Kerl,et al. Guidelines for the management of actinic keratoses. , 2006, European journal of dermatology : EJD.
[24] S. Shen,et al. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. , 2002, Journal of pharmaceutical sciences.